MedPath

SAPPORO study to Prove the Effects of telmisartan and valsartan on Early morning blood pressure based on amlodipine treatment

Not Applicable
Conditions
patients with essential hypertension
Registration Number
JPRN-UMIN000003922
Lead Sponsor
SPEED investigators
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
250
Inclusion Criteria

Not provided

Exclusion Criteria

allergy with ARB or amlodipine pregnancy severe liver dysfunction severe kidney dysfunction taking another antihypertensive agents patients who are not recomended Ca channel blocker as the first choice

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
primary outcome: home blood pressure in the early morning
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath